COVID-19 Misinformation

ABAI Statement on Spreading of Covid-19 Misinformation

The American Board of Allergy and Immunology (ABAI), in its role of public service to the specialty and medicine at large, expresses great concern over the public health hazard resulting from the spread of misinformation concerning COVID-19 viral infections and preventive COVID-19 vaccinations.  

ABAI respectfully endorses recent public statements from the  Federation of State Medical Boards , the  American Board of Medical Specialties , the  American Board of Emergency Medicine , the  American Board of Pathology and the joint statement by the  American Board of Family Medicine , American Board of Internal Medicine and the American Board of Pediatrics emphasizing the ethical and professional responsibility of physicians sharing information that is accurate and based on best available scientific evidence.

ABAI certified allergists-immunologists meet high standards for professional and ethical conduct. Certified diplomates are required to demonstrate a commitment to carrying out professional responsibilities, adherence to ethical principles and sensitivity to diverse patient populations. ABAI diplomates are accountable to each other, ABAI, state medical boards and the public.

Diplomates are specifically trained in vaccine immunology and adverse event management, thus serving as a valuable resource for patients. The ABAI Board of Directors and certified allergist-immunologists are increasingly concerned by the continued spread of COVID-19 vaccine misinformation impacting individual patients and communities nationwide. ABAI expects all diplomates as part of their professional commitment to patient safety and wellbeing to provide accurate and up to date information to patients and the public at all times.  

ABAI joins fellow certifying bodies in seeking meaningful solutions to eliminate the dissemination of COVID-19 infection and vaccine misinformation.